Volume 4 Number 4
Editorial
73
Observational studies of drug-eluting stents – some are more equal than others.EuroInterv.2009;4:419-423
EAPCI column
74
As time goes on... reflections. A greeting and ongoing wish-list from your EAPCIEuroInterv.2009;4:425-426
Focus article
75
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen S, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg P, Tariah I, Wallentin L, Windecker S
EuroInterv.2009;4:427-436
Clinical research
76
Effect of percutaneous mitral repair with the MitraClip® device on mitral valve area and gradientHerrmann H, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers J, Bommer W, Wang A, Berke A, Lerakis S, Kramer P, Chiu Wong S, Foster E, Glower D, Feldman T, on behalf of the EVEREST investigators
EuroInterv.2009;4:437-442
78
Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents – results of the multicentre FRIEND registryCarrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Levy G, Maupas E, Brunel P, Fajadet J, Le Breton H, Gilard M, Blanchard D, Glatt B, for the FRIEND investigators
EuroInterv.2009;4:449-456
79
Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcomeEuroInterv.2009;4:457-463
80
The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)EuroInterv.2009;4:464-474
81
Dual quantitative coronary angiography: a novel approach to quantify intracoronary thrombotic burdenAleong G, Vaqueriza D, del Valle R, Garcia H, Hernandez R, Alfonso F, Jimenez-Quevedo P, Bañuelos C, Macaya C, Escaned J
EuroInterv.2009;4:475-480
82
Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stentsGhimire G, Spiro J, Kharbanda R, Roughton M, Barlis P, Mason M, Ilsley C, DiMario C, Erbel R, Waksman R, Dalby M
EuroInterv.2009;4:481-484
83
Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patientsVoudris V, Kariofillis P, Thomopoulou S, Patsilinakos S, Manginas A, Spargias C, Pavlides G, Cokkinos D
EuroInterv.2009;4:485-491
84
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS IIVaina S, Voudris V, Morice M-C, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll H-P, Cokkinos D, Stefanadis C, Serruys PW, on behalf of the ARTS II Investigators
EuroInterv.2009;4:492-501
86
Integration of 3D reconstruction in the SELection criteria for Excessive Crossing Times for Magnetically Supported Percutaneous Coronary Intervention. SELECT-MPPatterson M, Hoeks S, Rijkenberg S, Ramcharitar S, van Guens RJ, Tanimoto S, van Domburg R, Serruys PW
EuroInterv.2009;4:509-516
87
Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumptionIJsselmuiden A, Patterson M, van Nooijen F, Tangelder G-J, Dirksen M, Amoroso G, Slagboom T, Serruys PW, Laarman G, Kiemeneij F
EuroInterv.2009;4:517-523
88
Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary interventionEuroInterv.2009;4:524-528
Expert review
89
Current and future developments in intracoronary optical coherence tomography imagingEuroInterv.2009;4:529-534
Experimental research
90
In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary modelEuroInterv.2009;4:534-541
How should I treat?
91
Coronary steal with unstable angina secondary to a coronary artery fistula EuroInterv.2009;4:542-548
Volume 4 Number 4 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Biotronik AG
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



